JP2013520999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013520999A5 JP2013520999A5 JP2012556250A JP2012556250A JP2013520999A5 JP 2013520999 A5 JP2013520999 A5 JP 2013520999A5 JP 2012556250 A JP2012556250 A JP 2012556250A JP 2012556250 A JP2012556250 A JP 2012556250A JP 2013520999 A5 JP2013520999 A5 JP 2013520999A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody fragment
- seq
- disease
- der
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31045010P | 2010-03-04 | 2010-03-04 | |
| US61/310,450 | 2010-03-04 | ||
| PCT/US2011/027094 WO2011109662A1 (en) | 2010-03-04 | 2011-03-03 | Monoclonal antibodies directed to cd52 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016130517A Division JP2017000142A (ja) | 2010-03-04 | 2016-06-30 | Ｃｄ５２に対するモノクローナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013520999A JP2013520999A (ja) | 2013-06-10 |
| JP2013520999A5 true JP2013520999A5 (https=) | 2014-04-17 |
Family
ID=44531535
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556250A Pending JP2013520999A (ja) | 2010-03-04 | 2011-03-03 | Ｃｄ５２に対するモノクローナル抗体 |
| JP2016130517A Pending JP2017000142A (ja) | 2010-03-04 | 2016-06-30 | Ｃｄ５２に対するモノクローナル抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016130517A Pending JP2017000142A (ja) | 2010-03-04 | 2016-06-30 | Ｃｄ５２に対するモノクローナル抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8652470B2 (https=) |
| EP (1) | EP2542258A4 (https=) |
| JP (2) | JP2013520999A (https=) |
| AU (2) | AU2011223547B2 (https=) |
| BR (1) | BR112012022342A2 (https=) |
| CA (1) | CA2791866A1 (https=) |
| WO (1) | WO2011109662A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2411050A4 (en) * | 2009-03-25 | 2013-07-17 | Vet Therapeutics Inc | ANTIBODY REGIONS WITH A CONSTANT DOMAIN AND THEIR USE |
| EP2542258A4 (en) | 2010-03-04 | 2013-08-21 | Vet Therapeutics Inc | ON CD52 MONOCLONAL ANTIBODIES |
| US9616120B2 (en) | 2010-03-04 | 2017-04-11 | Vet Therapeutics, Inc. | Monoclonal antibodies directed to CD20 |
| ES2704007T3 (es) * | 2011-05-06 | 2019-03-13 | Nexvet Australia Pty Ltd | Anticuerpos anti-factor de crecimiento nervioso y procedimientos de preparación y uso de los mismos |
| AU2012328819B2 (en) | 2011-10-26 | 2017-08-03 | Elanco Tiergesundheit Ag | Monoclonal antibodies and methods of use |
| MX357655B (es) | 2011-11-15 | 2018-07-18 | Walter & Eliza Hall Inst Medical Res | Mediador soluble. |
| US9778269B2 (en) * | 2012-11-15 | 2017-10-03 | The Walter And Eliza Hall Institute Of Medical Research | Method of treating sepsis by administering a soluble CD52 glycoprotein |
| JP6493692B2 (ja) * | 2013-03-15 | 2019-04-10 | セルジーン コーポレイション | 修飾されたｔリンパ球 |
| CN106029697B (zh) | 2013-12-20 | 2021-06-04 | 英特维特国际股份有限公司 | 具有经修饰的ch2-ch3序列的犬抗体 |
| WO2015121454A1 (en) * | 2014-02-14 | 2015-08-20 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
| CN107074952B (zh) | 2014-09-30 | 2021-04-09 | 英特维特国际股份有限公司 | 结合犬pd-l1的pd-l1抗体 |
| CA3005696A1 (en) | 2015-12-18 | 2017-06-22 | Intervet International B.V. | Caninized human antibodies to human and canine il-4r alpha |
| US11091556B2 (en) | 2015-12-18 | 2021-08-17 | Intervet Inc. | Caninized human antibodies to human IL-4R alpha |
| CN116368154A (zh) | 2020-10-08 | 2023-06-30 | 阿菲姆德股份有限公司 | 三特异性结合剂 |
| CA3216098A1 (en) | 2021-07-30 | 2023-02-02 | Uwe Reusch | Duplexbodies |
| US20260070986A1 (en) | 2021-11-03 | 2026-03-12 | Affimed Gmbh | Bispecific cd16a binders |
| CN116785434A (zh) * | 2023-03-29 | 2023-09-22 | 暨南大学附属第一医院（广州华侨医院） | 一种cd52+巨噬细胞作为骨关节炎治疗靶点的应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| AU640397B2 (en) | 1989-08-25 | 1993-08-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulin |
| US7084260B1 (en) | 1996-10-10 | 2006-08-01 | Genpharm International, Inc. | High affinity human antibodies and human antibodies against human antigens |
| ATE414768T1 (de) | 1991-04-10 | 2008-12-15 | Scripps Research Inst | Bibliotheken heterodimerer rezeptoren mittels phagemiden |
| JP3919830B2 (ja) * | 1992-11-28 | 2007-05-30 | 財団法人化学及血清療法研究所 | 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片 |
| US5910486A (en) | 1994-09-06 | 1999-06-08 | Uab Research Foundation | Methods for modulating protein function in cells using, intracellular antibody homologues |
| US6306393B1 (en) * | 1997-03-24 | 2001-10-23 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| JP3087696B2 (ja) | 1997-07-25 | 2000-09-11 | 日本電気株式会社 | 分散メモリ型マルチプロセッサ・システム制御方法およびコンピュータ読み取り可能な記録媒体 |
| US6573372B2 (en) | 1999-01-07 | 2003-06-03 | Heska Corporation | Feline immunoglobulin E molecules and compositions there of |
| EP1246607B1 (en) | 1999-12-30 | 2007-06-27 | Dana-Farber Cancer Institute, Inc. | Proteoliposomes containing an integral membrane protein having one or more transmembrane domains |
| US6703360B2 (en) | 2000-04-07 | 2004-03-09 | Heska Corporation | Compositions and methods related to canine IgG and canine IL-13 receptors |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| AU2002359568B2 (en) * | 2001-12-03 | 2008-02-21 | Alexion Pharmaceuticals, Inc. | Hybrid antibodies |
| GB0129105D0 (en) | 2001-12-05 | 2002-01-23 | Celltech R&D Ltd | Expression control using variable intergenic sequences |
| US7261890B2 (en) | 2001-12-21 | 2007-08-28 | Idexx Laboratories, Inc. | Methods for using canine immunoglobulin variable domains and caninized antibodies |
| WO2003068821A2 (en) | 2002-02-14 | 2003-08-21 | Immunomedics, Inc. | Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| WO2003072736A2 (en) * | 2002-02-21 | 2003-09-04 | Duke University | Reagents and treatment methods for autoimmune diseases |
| AU2003244817B2 (en) | 2002-06-28 | 2010-08-26 | Domantis Limited | Antigen-binding immunoglobulin single variable domains and dual-specific constructs |
| ZA200503075B (en) | 2002-11-07 | 2006-09-27 | Immunogen Inc | Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| US7264806B2 (en) * | 2003-11-01 | 2007-09-04 | Biovation Ltd. | Modified anti-CD52 antibody |
| US7531628B2 (en) * | 2004-05-28 | 2009-05-12 | Idexx Laboratories, Inc. | Canine CD20 compositions |
| EP1778726A4 (en) | 2004-08-16 | 2009-03-18 | Medimmune Inc | INTEGRIN ANTAGONISTS WITH IMPROVED ANTIBODY-DEPENDENT CELL-ASSAYED CYTOTOXICITY ACTIVITY |
| AU2005335714B2 (en) | 2004-11-10 | 2012-07-26 | Macrogenics, Inc. | Engineering Fc antibody regions to confer effector function |
| ES2971647T3 (es) | 2005-04-15 | 2024-06-06 | Macrogenics Inc | Diacuerpos covalentes y usos de los mismos |
| WO2006126068A2 (en) | 2005-05-24 | 2006-11-30 | Avestha Gengraine Technologies Pvt Ltd | Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia |
| PL2573114T3 (pl) | 2005-08-10 | 2016-10-31 | Identyfikacja i inżynieria przeciwciał z wariantami regionów FC oraz sposoby ich stosowania | |
| CA2646508A1 (en) | 2006-03-17 | 2007-09-27 | Biogen Idec Ma Inc. | Stabilized polypeptide compositions |
| TW200831528A (en) | 2006-11-30 | 2008-08-01 | Astrazeneca Ab | Compounds |
| GB0707640D0 (en) | 2007-04-20 | 2007-05-30 | Strathclyde | Acoustic deterrence |
| EP2331579B1 (en) | 2008-09-04 | 2017-07-05 | Vet Therapeutics, Inc. | Monoclonal antibodies |
| EP2411050A4 (en) | 2009-03-25 | 2013-07-17 | Vet Therapeutics Inc | ANTIBODY REGIONS WITH A CONSTANT DOMAIN AND THEIR USE |
| WO2011109108A1 (en) | 2010-03-04 | 2011-09-09 | Vet Therapeutics Inc. | Monoclonal antibodies directed to cd20 |
| EP2542258A4 (en) | 2010-03-04 | 2013-08-21 | Vet Therapeutics Inc | ON CD52 MONOCLONAL ANTIBODIES |
-
2011
- 2011-03-03 EP EP11751388.7A patent/EP2542258A4/en not_active Withdrawn
- 2011-03-03 JP JP2012556250A patent/JP2013520999A/ja active Pending
- 2011-03-03 CA CA2791866A patent/CA2791866A1/en not_active Abandoned
- 2011-03-03 BR BR112012022342A patent/BR112012022342A2/pt not_active IP Right Cessation
- 2011-03-03 WO PCT/US2011/027094 patent/WO2011109662A1/en not_active Ceased
- 2011-03-03 US US13/040,170 patent/US8652470B2/en active Active
- 2011-03-03 AU AU2011223547A patent/AU2011223547B2/en not_active Ceased
-
2014
- 2014-01-17 US US14/158,653 patent/US20140341912A1/en not_active Abandoned
-
2016
- 2016-06-30 JP JP2016130517A patent/JP2017000142A/ja active Pending
- 2016-08-05 AU AU2016210744A patent/AU2016210744A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520999A5 (https=) | ||
| JP2013520990A5 (https=) | ||
| Cambridge et al. | B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response | |
| Kortlever et al. | Myc cooperates with Ras by programming inflammation and immune suppression | |
| WO2011050106A3 (en) | Anti-cd3 antibody dosing in autoimmune disease | |
| Piccione et al. | A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells | |
| JP2012121878A5 (https=) | ||
| Pomés et al. | 100 Years later: Celebrating the contributions of x-ray crystallography to allergy and clinical immunology | |
| JP2020511123A5 (https=) | ||
| UA105768C2 (uk) | Антитіла до рецептора кінцевих продуктів глибокого глікування (rage) і їх застосування | |
| UA115439C2 (uk) | Гуманізоване антитіло, яке розпізнає альфа-синуклеїн | |
| BR112013028523A8 (pt) | Uso de um anticorpo ou uma proteína de fusão ou um fragmento de ligação da mesma e método para a purificação de um anticorpo, uma proteína de fusão ou um fragmento de ligação da mesma de uma mistura fonte | |
| JP2012254083A5 (https=) | ||
| JO3764B1 (ar) | جزيئات إرتباط il-18 | |
| DOP2013000129A (es) | PROTEÍNAS DE UNIÓN AL TNF-a. | |
| MX379660B (es) | Anticuerpo anti-receptor de linfocitos t alfa-beta. | |
| MX377475B (es) | Anticuerpo monoclonal de interleucina-31. | |
| JO3097B1 (ar) | الأجسام المضادة c-Met | |
| BR112016014284A2 (pt) | anticorpo caninizado isolado ou um fragmento de ligação de antígeno do mesmo, ácido nucleico isolado, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos para aumentar a atividade de uma célula imune e para produzir um anticorpo caninizado ou fragmento de ligação de antígeno do mesmo | |
| BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
| JP2011184466A5 (https=) | ||
| FI3736291T3 (fi) | Anti-fcrh5-vasta-aineita | |
| JP2014061000A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| NZ629178A (en) | Antibodies to matrix metalloproteinase 9 |